跳至主要内容
临床试验/NCT03704506
NCT03704506Unknown4 期

A Randomized, Double-blind, Placebo-controlled, Multicenter Clinical Trial of the Efficacy and Safety of Treating Acute Tonsillitis With Reyanning Mixture Alone/in Combination With Antibiotics.

China Academy of Chinese Medical Sciences0 个研究点目标入组 144 人开始时间: 2018年10月22日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
入组人数
144
主要终点
recovery time

研究概览

简要总结

The purpose of this study is to evaluate the efficacy and safety of treating with acute tonsillitis using Reyanning mixture alone/in combination with antibiotics, and its function of reducing the use of antibiotics.

详细描述

In order to evaluate the efficacy,safety and the function of reducing the use of antibiotics of Reyanning mixture (a mixture of Chinese herbal medicine) in treating with acute tonsillitis, a randomized, double-blind, placebo-controlled, multicenter clinical trials will be established. According to the relevant regulations of the China Food and Drug Administration(CFDA), 144 cases need to be registered at least. The aim population is who suffering of acute tonsillitis from October 2018 to December 2019.These cases will be randomly divided into treatment group 1(Reyanning mixture +amoxil capsule simulator),treatment group 2(Reyanning mixture +amoxil capsule) and control group(Reyanning mixture simulator +amoxil capsule).Each group will be treated for 7 days and followed up for 3 times . The main indicators include the recovery time/rate and antibiotic duration/dosage. And the vanish rate of single symptom/physical sign, the ratio of white blood cell count(WBC) recovery, the time of fever will be observed as well.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Double (Participant, Investigator)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Meet the diagnostic criteria of acute tonsillitis;
  • Meet the traditional Chinese medicine symptom diagnostic criteria of external wind-heat type and excessive heat in the lung and stomach type;
  • 18 years≤age≤65 years;
  • course of disease within 72 hours;
  • sign informed consent.

排除标准

  • common cold,influenza, acute laryngopharyngitis, pharyngeal diphtheria, wensang's isthmitis.
  • complicated with acute tracheobronchitis,pneumonia,rheumatic fever, acute glomerulonephritis or rheumatic heart disease.
  • complicated with severe angiocardiopathy, cerebrovascular disease, hemopoietic system disease or psychopath.
  • liver or kidney function is abnormal(ALT>1.5 times upper limit of normal; Cr>upper limit of normal); diabetic.
  • WBC<10×109/L and neutrophilic granulocyte percentage<75%;or WBC ≥20×109/L;
  • gestational, lactating women or who planning to get pregnant within half a year.
  • already accept similar traditional Chinese medicine or antibiotic within 48 hours before registered.
  • joining other clinical trials or allergic to any drug in this trials.

研究组 & 干预措施

treatment group 1

Experimental

Reyanning mixture+amoxil capsule simulator

干预措施: Reyanning mixture (Drug)

treatment group 1

Experimental

Reyanning mixture+amoxil capsule simulator

干预措施: amoxil capsule simulator (Drug)

treatment group 2

Experimental

Reyanning mixture +amoxil capsule

干预措施: Reyanning mixture (Drug)

treatment group 2

Experimental

Reyanning mixture +amoxil capsule

干预措施: amoxil capsule (Drug)

control group

Active Comparator

Reyanning mixture simulator +amoxil capsule

干预措施: amoxil capsule (Drug)

control group

Active Comparator

Reyanning mixture simulator +amoxil capsule

干预措施: Reyanning mixture simulator (Drug)

结局指标

主要结局

recovery time

时间窗: after 7 days of medication

The recovery time will be observed. Recovery means that the main signs and symptoms score is zero, and body temperature is below 37.3 ℃ maintaining for at least 24 hours.

recovery rate

时间窗: after 7 days of medication

The recovery rate will be observed. Recovery means that the main signs and symptoms score is zero, and body temperature is below 37.3 ℃ maintaining for at least 24 hours.

antibiotic dosage

时间窗: after 7 days of medication

The dosage of antibiotic will be observed.

antibiotic duration

时间窗: after 7 days of medication

The duration of antibiotic will be observed.

次要结局

  • the vanish rate of single symptom/physical sign(after 7 days of medication)
  • the ratio of WBC recovery(after 7 days of medication)
  • the time of fever relieving(after 7 days of medication)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Yanming Xie

Deputy director

China Academy of Chinese Medical Sciences

相似试验

Registration of the Study of Reyanning Mixture | 临床试验